Breast cancer flags | Positive predictive value | Sensitivity | Specificity |
---|---|---|---|
45 and Up Study baseline, Medicare Benefits Schedule and Pharmaceutical Benefits Scheme | |||
Breast radiotherapy AND dispensed medicine | 80.1% | 40.3% | 99.9% |
Breast radiotherapy OR dispensed medicine1 | 47.9% | 82.7% | 98.7% |
Breast radiotherapy AND self-reported diagnosis | 69.3% | 36.1% | 99.9% |
Breast radiotherapy AND dispensed medicine AND self-reported diagnosis2 | 72.1% | 23.9% | 99.9% |
(Breast radiotherapy OR dispensed medicine) AND self-reported diagnosis | 58.6% | 60.4% | 99.8% |
Breast radiotherapy OR dispensed medicine OR self-reported diagnosis | 27.0% | 95.3% | 97.7% |
Admitted Patients Data Collection, 45 and Up Study baseline, Medicare Benefits Schedule and Pharmaceutical Benefits Scheme | |||
(Lumpectomy or mastectomy) AND diagnosis of invasive breast cancer AND breast radiotherapy | 90.1% | 47.5% | 99.9% |
(Lumpectomy or mastectomy) AND diagnosis of invasive breast cancer AND breast radiotherapy AND dispensed medicine | 89.7% | 33.7% | 99.9% |
(Lumpectomy or mastectomy) AND diagnosis of invasive breast cancer AND dispensed medicine | 87.8% | 55.0% | 99.9% |
(Lumpectomy or mastectomy) AND (diagnosis of invasive breast cancer OR breast radiotherapy) | 83.0% | 83.2% | 99.8% |
(Lumpectomy or mastectomy) AND (diagnosis of invasive breast cancer OR dispensed medicine) | 84.1% | 83.1% | 99.8% |
(Lumpectomy or mastectomy) AND (diagnosis of invasive breast cancer OR breast radiotherapy OR dispensed medicine) | 80.5% | 83.6% | 99.7% |
(Lumpectomy or mastectomy) AND diagnosis of invasive breast cancer AND self-reported diagnosis | 88.5% | 71.1% | 99.9% |
(Lumpectomy or mastectomy) AND diagnosis of invasive breast cancer AND breast radiotherapy AND self-reported diagnosis | 87.3% | 29.4% | 99.9% |